Effects of statins on C-reactive protein and interleukin-6 (The Ludwigshafen Risk and Cardiovascular Health Study)

被引：43

作者：

März, W

Winkler, K

Nauck, M

Böhm, BO

Winkelmann, BR

机构：

[1] Univ & Gen Hosp, Inst Clin Med, A-8036 Graz, Austria

[2] Univ & Gen Hosp, Chem Lab Diagnost, A-8036 Graz, Austria

[3] United Hosp, Dept Med, Div Clin Chem, Freiburg, Germany

[4] Univ Hosp, Dept Med, Div Endocrinol, Ulm, Germany

[5] Heidelberg Univ, Dept Pharmacogenom & Appl Genome Res, Heidelberg, Germany

来源：

AMERICAN JOURNAL OF CARDIOLOGY | 2003年 / 92卷 / 03期

关键词：

D O I：

10.1016/S0002-9149(03)00633-7

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

This report provides preliminary evidence that statins may lower C-reactive protein levels by interfering with the generation and/or release of C-reactive protein in the liver rather than by modulating inflammatory processes in the vessel wall. (C)2003 by Excerpta Medica, Inc.

引用

页码：305 / 308

页数：4

共 16 条

[1] Effect of statin therapy on C-reactive protein levels - The Pravastatin Inflammation/CRP Evaluation (PRINCE): A randomized trial and cohort study [J].